Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001850207 | SCV002282463 | uncertain significance | Hypertrophic cardiomyopathy | 2022-04-28 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 180973). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This variant has not been reported in the literature in individuals affected with MYBPC3-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 845 of the MYBPC3 protein (p.Arg845Gly). |
All of Us Research Program, |
RCV001850207 | SCV004827127 | uncertain significance | Hypertrophic cardiomyopathy | 2023-06-28 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV001541900 | SCV001760544 | uncertain significance | Cardiomyopathy | no assertion criteria provided | clinical testing |